What Is Addiction? History, Terminology, and Core Concepts.
Olsen Y.
Med Clin North Am. 2022 Jan;106(1):1-12. doi: 10.1016/j.mcna.2021.08.001.
The Opioid Crisis and the Future of Addiction and Pain Therapeutics.
Coussens NP, Sittampalam GS, Jonson SG, Hall MD, Gorby HE, Tamiz AP, McManus OB, Felder CC, Rasmussen K.
J Pharmacol Exp Ther. 2019 Nov;371(2):396-408. doi: 10.1124/jpet.119.259408. Epub 2019 Sep 3.
Ketamine for the treatment of addiction: Evidence and potential mechanisms.
Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJA.
Neuropharmacology. 2018 Nov;142:72-82. doi: 10.1016/j.neuropharm.2018.01.017. Epub 2018 Jan 12.
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.
Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN.
Pain. 2015 Apr;156(4):569-576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
How addictive are gabapentin and pregabalin? A systematic review.
Bonnet U, Scherbaum N.
Eur Neuropsychopharmacol. 2017 Dec;27(12):1185-1215. doi: 10.1016/j.euroneuro.2017.08.430. Epub 2017 Oct 5.
Addiction and the cerebellum with a focus on actions of opioid receptors.
Ranjbar H, Soti M, Banazadeh M, Saleki K, Kohlmeier KA, Shabani M.
Neurosci Biobehav Rev. 2021 Dec;131:229-247. doi: 10.1016/j.neubiorev.2021.09.021. Epub 2021 Sep 20.
[Heroin addiction].
Hosztafi S.
Acta Pharm Hung. 2011;81(4):173-83.
ANALGESIA AND ADDICTION.
MELLETT LB, WOODS LA.
Fortschr Arzneimittelforsch. 1963;5:155-267. doi: 10.1007/978-3-0348-7047-4_2.
Current status of immunotherapies for addiction.
Xu A, Kosten TR.
Ann N Y Acad Sci. 2021 Apr;1489(1):3-16. doi: 10.1111/nyas.14329. Epub 2020 Mar 8.
Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.
Kibaly C, Alderete JA, Liu SH, Nasef HS, Law PY, Evans CJ, Cahill CM.
Cell Mol Neurobiol. 2021 Jul;41(5):899-926. doi: 10.1007/s10571-020-01013-y. Epub 2020 Nov 27.
